ERC Consolidator Grant · 2019
Tissue-engineering the tumour microenvironment to improve treatment of pancreatic cancer
My vision is to address a clinical problem with a novel and transformative approach. Using my unique expertise in cell biology, tissue engineering and translational research I will design technology platforms to test new treatments for human pancreatic cancer. Pancreatic tumours are cancers of unmet medical need with 85% of patients dying within 9 months of diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between malignant and non-malignant cells. Biomimetic tissue engineering is a powerful approach to generate 3D cancer models, however, only a few scientists use these technologies. Most 3D cultures of…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.
← All labs at Leibniz Institute of Polymer Research Dresden (IPF)